{
  "meta": {
    "title": "Anti_-_Parasitic_Drugs",
    "url": "https://brainandscalpel.vercel.app/anti-parasitic-drugs-cc99b685.html",
    "scrapedAt": "2025-11-30T11:19:39.740Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Mefloquine</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">HCQ</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An international traveller is travelling to the Caribbean. Which of the following drugs is advisable for the prophylaxis of Malaria?</span></p>",
      "unique_key": "DT1176773",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176773,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Current recommendations from the <strong>Centre for Disease Control and Prevention (CDC) </strong>include the use of <strong>chloroquine</strong> for chemoprophylaxis in the few areas infested by only chloroquine-sensitive malaria parasites (principally the <strong>Caribbean and Central America west of the Panama Canal)</strong></li>\n<li>When patients are counseled on the prevention of malaria, it is imperative to emphasize measures to <strong>prevent mosquito bites</strong> (e.g., using insect repellents, insecticides, and bed nets), because parasites are increasingly resistant to multiple drugs, and no chemoprophylactic regimen is fully protective.</li>\n</ul>\n<p><strong>Chemoprophylactic Drugs for Travelers</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509041b612ff7-2697-4230-8cc1-ac3761055def.png\">\n<ul>\n<li>Primaquine and Tafenoquine are <strong>not first-line</strong> for primary prevention unless specific risk (e.g., <em>P. vivax</em> exposure).</li>\n</ul>\n<p><strong>Note:</strong></p>\n<ul>\n<li><strong>&lt;6 weeks travel - Doxycycline</strong> can be given, but C/I in pregnant and child, where <strong>Proguanil</strong> can be used</li>\n<li><strong>&gt;6 weeks travel - Mefloquine </strong>has <strong>Neuropsychiatric symptoms </strong>side effects; therefore contraindicated in critical workers like pilots. In that case, <strong>chloroquine</strong> can be used.</li>\n</ul>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe hypertension</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe hypotension</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">CNS depression</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old boy diagnosed with Plasmodium vivax malaria was admitted for treatment. Due to the unavailability of other antimalarials, he was given IV chloroquine, which was infused rapidly. What is the likely adverse outcome?</span></p>",
      "unique_key": "DT1176785",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176785,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Large intramuscular injections or rapid intravenous infusions of <strong>chloroquine</strong> hydrochloride can result in <strong>severe hypotension</strong> and <strong>cardiac arrest</strong>.</li>\n<li>Parenteral administration of chloroquine is best avoided, but if other drugs are not available for parenteral use, it should be infused slowly.</li>\n</ul>\n<p>Mechanism of <strong>Severe Hypotension</strong> due to <strong>Rapid IV Infusion of Chloroquine:</strong></p>\n<ul>\n<li><strong>Direct myocardial depression:</strong> Chloroquine in high concentrations depresses myocardial contractility, reducing cardiac output. It also inhibits Na<sup>+</sup> and K<sup>+</sup> ion channels, affecting cardiac conduction and contractility.</li>\n<li><strong>Vasodilation:</strong> Rapid infusion causes peripheral vasodilation, lowering systemic vascular resistance. This results in a sudden drop in blood pressure.</li>\n<li><strong>Negative chronotropic and dromotropic effects:</strong> Chloroquine reduces heart rate (bradycardia) and slows AV conduction, potentially leading to arrhythmias and reduced cardiac output.</li>\n<li><strong>QT prolongation and arrhythmias:</strong> High serum levels from rapid infusion prolong the QT interval, predisposing to torsades de pointes and sudden cardiovascular collapse.</li>\n</ul>\n<p><strong>General Tolerance of Chloroquine: </strong>Usually well tolerated, even with prolonged use.</p>\n<p><strong>Common Adverse Effects of Chloroquine:</strong></p>\n<ul>\n<li><strong>Pruritus (especially common in Africans)</strong></li>\n<li><strong>Gastrointestinal: </strong>Nausea, Vomiting, Abdominal pain, Anorexia</li>\n<li><strong>Neurological: </strong>Headache, Malaise, Blurring of vision</li>\n<li><strong>Dermatological: </strong>Urticaria</li>\n</ul>\n<p><strong>Rare but Serious Adverse Effects:</strong></p>\n<ul>\n<li><strong>Hematologic: </strong>Hemolysis in G6PD-deficient individuals, Agranulocytosis</li>\n<li><strong>Neuropsychiatric: </strong>Impaired hearing, Confusion, Psychosis, Seizures</li>\n<li><strong>Dermatological: </strong>Exfoliative dermatitis, Alopecia, Bleaching of hair</li>\n<li><strong>Cardiovascular: </strong>Hypotension, ECG changes</li>\n</ul>\n<p><strong>Long-Term High-Dose Toxicities (mainly in rheumatologic use):</strong></p>\n<ul>\n<li>Ototoxicity (hearing loss)</li>\n<li>Retinopathy (may be irreversible)</li>\n<li>Myopathy</li>\n<li>Peripheral neuropathy</li>\n</ul>\n<p><strong>Intramuscular or rapid intravenous chloroquine hydrochloride can cause:</strong></p>\n<ul>\n<li>Severe hypotension</li>\n<li>Respiratory arrest</li>\n<li>Cardiac arrest</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Severe hypertension(Option A): </strong>Chloroquine does <strong>not</strong> cause hypertension. It actually leads to <strong>vasodilation and hypotension</strong> when infused rapidly.</p>\n<p><strong>CNS depression(Option C): </strong>While CNS effects like confusion or seizures may occur <strong>with overdose</strong>, CNS depression is not the <strong>immediate</strong> effect of rapid IV administration.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Melarone</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old male patient is on treatment for psoriasis. He came to OPD with the complaints of malaise, easy fatiguability, and fever with chills. He was diagnosed with malaria fever upon laboratory investigation. Which of the following drugs is contraindicated?</span></p>",
      "unique_key": "DT1176788",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176788,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Chloroquine</strong> is contraindicated in patients with <strong>psoriasis</strong> or porphyria, in whom it may precipitate <strong>acute attacks</strong> of these diseases.</li>\n<li>Possibly due to immune modulation and effects on epidermal proliferation.</li>\n<li>Safe in pregnancy and young children.</li>\n</ul>\n<p><strong>Contraindications of Chloroquine:</strong></p>\n<ul>\n<li><strong>Psoriasis: Chloroquine </strong>may worsen skin lesions.</li>\n<li><strong>Porphyria: </strong>It increases the risk of triggering acute attacks.</li>\n<li><strong>Retinal or visual field abnormalities: </strong>Increased risk of worsening vision damage<strong>.</strong></li>\n<li><strong>Myopathy: Chloroquine </strong>may aggravate muscle weakness<strong>.</strong></li>\n</ul>\n<p>Use with caution in patients with<strong> Liver disease</strong>, <strong>Neurologic disorders,</strong> and <strong>Hematologic disorders</strong></p>\n<p>Avoid coadministration with<strong> Kaolin (antidiarrheal) </strong>and<strong> Calcium- and magnesium-containing antacids, </strong>as they may interfere with chloroquine absorption.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Primaquine(Option A): </strong>Not specifically contraindicated in psoriasis. However, caution is required in <strong>G6PD deficiency</strong> due to the risk of hemolysis, not psoriasis.<em><br /> </em></p>\n<p><strong>Malarone(Option C): Atovaquone + Proguanil, </strong>Not contraindicated in psoriasis. Generally well tolerated and safe for most patients, including those with skin conditions.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Tissue Schizonticides</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood Schizonticides</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Gametocides</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Sporonticide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old male presents to the clinic with complaints of fever, chills, and headache for 3 days. A peripheral blood smear confirms Plasmodium vivax infection. He has no comorbidities and is not on any medications. The physician initiates treatment with chloroquine. Which of the following best explains chloroquine's primary mechanism of action in this patient?</span></p>",
      "unique_key": "DT1176790",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176790,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>When not limited by resistance, <strong>chloroquine</strong> is a highly effective <strong>blood schizonticide</strong>.</li>\n<li>It is also moderately effective against gametocytes of <em>P vivax, P ovale, </em>and <em>P malariae </em>but not against those of <em>P falciparum.</em></li>\n</ul>\n<p><strong>Chloroquine: </strong></p>\n<p>Chloroquine has been a mainstay in the <strong>treatment and prophylaxis of malaria</strong></p>\n<p><strong>Mechanism of Action:</strong></p>\n<ul>\n<li>Acts as a <strong>blood schizonticide</strong>.</li>\n<li>Concentrates in the <strong>parasite's food vacuole</strong> and inhibits <strong>biocrystallization</strong> of heme into <strong>hemozoin,</strong> which leads to <strong>toxic buildup of free heme</strong>, killing the parasite.</li>\n</ul>\n<p><strong>Pharmacokinetics:</strong></p>\n<ul>\n<li><strong>Type</strong>: Synthetic 4-aminoquinoline.</li>\n<li><strong>Formulation</strong>: Administered as the phosphate salt for <strong>oral use</strong>.</li>\n<li><strong>Absorption</strong>: Rapid and almost complete from the GI tract.</li>\n<li><strong>Time to Peak</strong>: Maximum plasma concentration reached in ~3 hours.</li>\n<li><strong>Distribution</strong>:\n<ul>\n<li>Very large <strong>volume of distribution</strong>: 100-1000 L/kg.</li>\n<li>Rapidly distributed to tissues.</li>\n</ul>\n</li>\n<li><strong>Metabolism &amp; Excretion</strong>:\n<ul>\n<li>Slowly released from tissues and metabolized.</li>\n<li>Primarily excreted in <strong>urine</strong>.</li>\n</ul>\n</li>\n<li><strong>Half-life</strong>:\n<ul>\n<li>Initial: 3-5 days.</li>\n<li>Terminal: 1-2 months (due to tissue binding).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Resistance:</strong></p>\n<ul>\n<li>Common in <em>P. falciparum</em>, emerging in <em>P. vivax</em>.</li>\n<li>Caused by mutations in <strong>PfCRT (Plasmodium falciparum Chloroquine Resistance Transporter)</strong>.</li>\n<li>Resistance can be <strong>partially reversed</strong> by:\n<ul>\n<li>Verapamil</li>\n<li>Desipramine</li>\n<li>Chlorpheniramine</li>\n</ul>\n</li>\n</ul>\n<p><strong>Clinical Uses</strong></p>\n<p><strong>1. Treatment:</strong></p>\n<ul>\n<li>Drug of choice for <strong>Uncomplicated non-falciparum malaria</strong> and <strong>Sensitive P. falciparum infections</strong>.</li>\n<li>Reduces fever in <strong>24-48 hours</strong> and clears parasitemia in <strong>48-72 hours</strong>.</li>\n<li>Not active against the <strong>Liver stages</strong> of <em> vivax</em> or <em>P. ovale</em> and <strong>Gametocytes</strong>.</li>\n<li>Must be combined with <strong>primaquine or tafenoquine</strong> for radical cure of <em> vivax</em> and <em>P. ovale</em>.</li>\n</ul>\n<p><strong>2. Chemoprophylaxis: Preferred agent</strong> in regions <strong>without chloroquine resistance</strong>. For full eradication of liver stages (<em>P. vivax</em>, <em>P. ovale</em>), <strong>add primaquine</strong> after chloroquine.</p>\n<p><strong>3. Amebic Liver Abscess</strong></p>\n<ul>\n<li>Achieves <strong>high liver concentrations</strong>.</li>\n<li>Useful as an <strong>alternative agent</strong> in patients not responding to <strong>metronidazole</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Tissue Schizonticides(Option A): Agents </strong>acting on liver-stage (exoerythrocytic) parasites. Example: Primaquine. Chloroquine does not eliminate hepatic forms.</p>\n<p><strong>Gametocides(Option C): Agents </strong>targeting the sexual forms (gametocytes) in the blood to prevent transmission. Chloroquine is only partially effective here, mainly in <em>P. vivax</em>, not <em>P. falciparum</em>.</p>\n<p><strong>Sporonticide(Option D):</strong> Sporonticides are antimalarial agents that act on the sexual forms of the malaria parasite within the mosquito (not the human host). Examples: Primaquine, Tafenoquine. Chloroquine does <strong>not prevent transmission</strong> via mosquitoes and has <strong>no significant activity</strong> against gametocytes or sporogonic stages.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Artemisinin is available for intravenous use</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">They are very rapidly acting blood schizonticides</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">They do not affect the hepatic stage</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following sentences is false for Artemisinin?</span></p>",
      "unique_key": "DT1176791",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176791,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Artemisinin &amp; Its Derivatives:</strong></p>\n<ul>\n<li><strong>Artemisinin (qinghaosu): </strong>A <strong>sesquiterpene lactone endoperoxide</strong> derived from <em>Artemisia annua</em>, used in Chinese medicine for over 2000 years.</li>\n<li><strong>Parent compound:</strong> Insoluble, used only orally.</li>\n<li><strong>Derivatives (Improved solubility &amp; efficacy):</strong>\n<ul>\n<li><strong>Artesunate</strong>: Water-soluble; IV, IM, oral, rectal</li>\n<li><strong>Artemether</strong>: Lipid-soluble; IM, oral, rectal</li>\n<li><strong>Dihydroartemisinin</strong>: Water-soluble; oral only</li>\n</ul>\n</li>\n</ul>\n<p><strong>Pharmacokinetics: </strong></p>\n<ul>\n<li>Rapid absorption</li>\n<li><strong>Metabolism:</strong> All convert to <strong>dihydroartemisinin</strong> (active form)</li>\n<li><strong>Half-life:</strong>\n<ul>\n<li><strong>Artesunate/DHA</strong>: 30-60 mins</li>\n<li><strong>Artemether</strong>: 2-3 hours</li>\n</ul>\n</li>\n<li>Drug levels fall with continued therapy due to enzyme induction.</li>\n</ul>\n<p><strong>Mechanism of Action: </strong></p>\n<ul>\n<li><strong>Rapidly acting blood schizonticides</strong> (active against all human malaria species)<strong>(Option B ruled out)</strong></li>\n<li>Generates <strong>free radicals</strong> via iron-catalyzed cleavage of the endoperoxide bridge &rarr; damages parasite proteins.</li>\n<li><strong>No effect on hepatic stages(Option C ruled out)</strong></li>\n<li>Active against <strong>young gametocytes</strong>, not mature ones.</li>\n</ul>\n<p><strong>Clinical Uses: </strong></p>\n<h4><strong>Uncomplicated Falciparum Malaria</strong></h4>\n<ul>\n<li>Always used as <strong>Artemisinin-Based Combination Therapy (ACT)</strong> to improve efficacy and prevent resistance</li>\n<li><strong>Common ACTs:</strong>\n<ul>\n<li>Artemether + Lumefantrine (Coartem)</li>\n<li>Artesunate + Amodiaquine</li>\n<li>Artesunate + Mefloquine</li>\n<li>Dihydroartemisinin + Piperaquine</li>\n<li>Artesunate + Pyronaridine</li>\n</ul>\n</li>\n</ul>\n<h4><strong>Severe Malaria</strong></h4>\n<ul>\n<li><strong>First-line: IV Artesunate(Option A ruled out)</strong>\n<ul>\n<li>Superior to quinine in terms of survival and side-effect profile</li>\n<li>IM Artemether or rectal formulations are alternatives if IV is not available</li>\n</ul>\n</li>\n</ul>\n<p><strong>Adverse Effects: </strong></p>\n<ul>\n<li><strong>Commonly</strong> Nausea, vomiting, dizziness (may overlap with malaria symptoms)</li>\n<li><strong>Serious (rare):</strong>\n<ul>\n<li>Neutropenia, anemia, hemolysis (delayed hemolysis in ~13% cases post-severe malaria treatment)</li>\n<li>Elevated liver enzymes</li>\n<li>Allergic reactions</li>\n</ul>\n</li>\n<li><strong>Neurotoxicity</strong>: Seen in animals at high doses only</li>\n<li><strong>Embryotoxicity in animals</strong>, but <strong>safe in pregnancy</strong> (2nd &amp; 3rd trimesters)</li>\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">2,4</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following sentences are TRUE for the use of artemisinin-based combination therapy in pregnancy?<br>1. Recommended for uncomplicated falciparum malaria in the 2nd & 3rd trimesters<br>2. Not recommended for uncomplicated falciparum malaria in the 2nd & 3rd trimesters<br>3. Intravenous artesunate can be used for severe malaria in 1st trimester<br>4. Intravenous artesunate cannot be used for severe malaria in 1st trimester</span></p>",
      "unique_key": "DT1176793",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176793,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>WHO recommends for use of artemisinin-based combination therapy in Pregnancy:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509041a7bcf5d-3150-42a8-9b56-b7232f933343.png\">\n<p><strong>Artemisinin is <em>relatively contraindicated</em> in the first trimester of pregnancy due to the following reasons:</strong></p>\n<p><strong>1. Animal Studies Showed Embryotoxicity:</strong></p>\n<ul>\n<li>In animal models (especially rodents), artemisinin and its derivatives have shown:\n<ul>\n<li>Embryotoxicity (damage to the embryo)</li>\n<li>Increased fetal resorption</li>\n<li>Developmental abnormalities</li>\n</ul>\n</li>\n<li>The critical window was during the early organogenesis period, the first trimester equivalent in humans.</li>\n</ul>\n<p><strong>2. Limited High-Quality Human Data:</strong></p>\n<ul>\n<li>Although human observational studies (especially from endemic areas) have not consistently shown increased risk of:\n<ul>\n<li>Congenital malformations</li>\n<li>Stillbirth</li>\n<li>Spontaneous abortions</li>\n</ul>\n</li>\n<li>The data is still limited, and due to ethical constraints, no large randomized trials have confirmed safety in 1st trimester.</li>\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">1,7</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">2,7</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">3,7</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an adverse effect of mefloquine?<br>1. Nausea and vomiting<br>2. Constipation<br>3. Diarrhoea<br>4. Sleep and behavioural disturbances<br>5. Headache<br>6. Abdominal pain<br>7.Peripheral neuropathy</span></p>",
      "unique_key": "DT1176795",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176795,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Mefloquine Adverse Effects:</strong></p>\n<ul>\n<li><strong>Common (GI &amp; Neuro): Nausea, vomiting</strong>, Epigastric pain, <strong>abdominal pain</strong>, <strong>diarrhea</strong>, <strong>Headache,</strong> dizziness, <strong>Sleep disturbances</strong>,<strong> behavioral disturbances,</strong> and Rash</li>\n<li><strong>Neuropsychiatric Toxicities:</strong>\n<ul>\n<li>Reported cases: <strong>seizures, psychosis, depression</strong></li>\n<li>2013 FDA: <strong>Black box warning</strong> for <strong>neurologic and psychiatric toxicity</strong></li>\n<li>Controlled studies: Serious AEs are <strong>rare but possible</strong></li>\n<li><strong>Long-term effects</strong> after short-term use are reported anecdotally</li>\n</ul>\n</li>\n<li><strong>Others: </strong>Leukocytosis, Thrombocytopenia, and Elevated liver enzymes (aminotransferases)</li>\n</ul>\n<h4><strong>Treatment Dosage (Higher Dose):</strong></h4>\n<ul>\n<li><strong>Increased adverse effects</strong>\n<ul>\n<li>10x higher rate of neuropsychiatric symptoms than the prophylactic dose</li>\n<li>Symptoms: <strong>depression, confusion, psychosis, seizures</strong></li>\n<li>Serious neuropsychiatric AEs: ~<strong>&lt;1 in 1000</strong>, though possibly underreported</li>\n</ul>\n</li>\n<li><strong>Cardiac Effects: Altered cardiac conduction</strong>, arrhythmias, bradycardia</li>\n</ul>\n<p><strong>Contraindications:</strong></p>\n<ul>\n<li>Epilepsy or seizure disorder</li>\n<li>Current or past psychiatric disorders</li>\n<li>Cardiac conduction abnormalities or arrhythmias</li>\n<li>Known hypersensitivity to mefloquine or related compounds</li>\n<li>Avoid combination with<strong> Quinine, Quinidine,</strong> and<strong> Halofantrine</strong></li>\n<li><strong>If quinine is needed after mefloquine prophylaxis</strong>, monitor closely (risk of QT prolongation)</li>\n<li><strong>Discontinue mefloquine</strong> if any <strong>neuropsychiatric symptoms</strong> develop during prophylaxis</li>\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Mefloquine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the only drug available acting against dormant hypnozoite stages of P vivax and P ovale</span></p>",
      "unique_key": "DT1176796",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176796,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Primaquine i</strong>s the drug of choice for the eradication of<strong> dormant liver forms of P vivax </strong>and<strong> P ovale </strong>and can also be used for<strong> chemoprophylaxis </strong>against <strong>all malarial species.</strong></p>\n<p><strong>Primaquine: </strong></p>\n<p><strong>Primaquine </strong>belongs to<strong> the 8-aminoquinolines</strong></p>\n<p><strong>Mechanism of Action: </strong></p>\n<ul>\n<li>Active against <strong>hepatic stages</strong> (including dormant hypnozoites) of <strong> vivax and P. ovale.</strong></li>\n<li>Also effective against <strong>gametocytes</strong> and has modest activity on <strong>asexual </strong>blood stages.</li>\n<li>The precise mechanism remains unknown<strong>.</strong></li>\n</ul>\n<p><strong>Adverse Effects: </strong></p>\n<p><strong>Commonly </strong>nausea, epigastric pain, cramps, headache (especially on an empty stomach), Dizziness, rash, diarrhea (more with tafenoquine)</p>\n<p><strong>Serious but rare:</strong></p>\n<ul>\n<li>Hemolysis (especially in G6PD deficiency)</li>\n<li>Methemoglobinemia (cyanosis)</li>\n<li>Leukopenia, agranulocytosis, arrhythmias</li>\n</ul>\n<p><strong>Clinical use: </strong></p>\n<ul>\n<li><strong>Radical cure </strong>of P. vivax and P. ovale malaria<strong> (</strong>eradicate hypnozoites in the liver)<strong>.</strong></li>\n<li>Terminal prophylaxis after travel to endemic areas<strong> (prevents relapse).</strong></li>\n<li><strong>Chemoprophylaxis </strong>against all malaria species (alternative regimens).</li>\n<li><strong>Gametocidal </strong>action against falciparum (reduces transmission).</li>\n<li>Treatment of <strong>Pneumocystis jirovecii </strong>(in combination with clindamycin, for mild-moderate disease).</li>\n</ul>\n<p><strong>Contraindications &amp; Cautions: </strong></p>\n<ul>\n<li><strong>G6PD deficiency: </strong>mandatory testing before use.\n<ul>\n<li>Tafenoquine is especially contraindicated due to its long half-life.</li>\n<li>In G6PD-deficient patients:\n<ul>\n<li>Consider weekly primaquine (45 mg) x 8 weeks with close monitoring</li>\n<li>Or postpone liver-stage therapy until relapse occurs.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Pregnancy:</strong> The Fetus is relatively G6PD-deficient and at risk of hemolysis.</li>\n<li><strong>Hematologic risk - Avoid in:</strong>\n<ul>\n<li>Myelosuppressed patients</li>\n<li>History of granulocytopenia or methemoglobinemia</li>\n<li>Concurrent use of myelosuppressive drugs</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Mefloquine(Option A): </strong>It is a <strong>Blood schizonticide</strong> which acts only on asexual blood stages of Plasmodium species. It has <strong>no action on liver stages</strong>, including hypnozoites of P. vivax/P. Ovale. Mainly used in prophylaxis and treatment of falciparum and vivax malaria (with additional drugs for relapse prevention).</p>\n<p><strong>Artesunate(Option C): </strong>It is an <strong>Artemisinin derivative</strong> and a rapidly acting <strong>blood schizonticide</strong>, has no hepatic stage activity (does not eradicate hypnozoites). Used treatment of severe malaria, especially P. falciparum.</p>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine with pentamidine</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine with doxycycline</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine with clindamycin</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine with azithromycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old male patient came to the OPD with complaints of high-grade fever, coughing, blood in sputum, and dyspnoea. His pulse rate is 120/min, BP is 110/76 mm Hg, SpO2 in room air is 98%. He has been on ART for 3 years and AKT for 2 months. Blood culture and BAL were sent to rule out secondary bacterial infection. The BAL report came positive for Pneumocystis jiroveci. Which regimen offers more tolerance in this patient in comparison to the commonly used trimethoprim-sulfamethoxazole regimen?</span></p>",
      "unique_key": "DT1176802",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176802,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The combination of <strong>clindamycin and primaquine</strong> is an alternative regimen in the treatment of <strong>pneumocystis</strong>, particularly <strong>mild to moderate disease.</strong></li>\n<li>This regimen offers improved tolerance compared with high-dose trimethoprim-sulfamethoxazole or pentamidine, although its efficacy against severe pneumocystis pneumonia is not well studied.</li>\n<li><strong>Clindamycin</strong>: anti-protozoal and antibacterial activity.</li>\n<li><strong>Primaquine</strong>: active against the trophic forms of P. jirovecii.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Primaquine with pentamidine(Option A): Both can cause severe hematologic and renal toxicity. Pentamidine (IV) is used as an alternative in severe PCP</strong>, but is <strong>less well tolerated</strong>, with risks of <strong>hypoglycemia, nephrotoxicity, hypotension, and pancreatitis</strong>. Not the best in terms of <strong>tolerability</strong>.</p>\n<p><strong>Primaquine with doxycycline (Option B): </strong>This combination is <strong>not standard or recommended</strong> for PCP. Doxycycline has <strong>no role</strong> in treating Pneumocystis jirovecii.</p>\n<p><strong>Primaquine with azithromycin(Option D): Not a standard regimen</strong> for PCP. Azithromycin is used for <strong>toxoplasmosis prophylaxis</strong> and <strong>MAC infections</strong>, not PCP.</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Ofloxacin</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Meropenem</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Paromomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old male patient came to the OPD with complaints of diarrhoea, mild fever, and weakness. His pulse rate is 100/min and BP is 100/70 mm Hg. He has already been treated with antibacterial drugs, which did not work. The physician is suspecting amebiasis. Which is the drug of choice for the treatment of extraluminal amebiasis?</span></p>",
      "unique_key": "DT1176803",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176803,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Metronidazole, a nitroimidazole, is the drug of choice in the treatment of extraluminal amebiasis.</li>\n<li><strong>Extraluminal amebiasis</strong> refers to invasive forms of infection caused by <em>Entamoeba histolytica</em>, such as <strong>Amebic liver abscess, </strong>Amebic peritonitis, Pulmonary, cerebral, or other systemic involvement</li>\n<li>It is usually <strong>followed by</strong> a <strong>luminal amebicide</strong> like <strong>paromomycin</strong> or <strong>diloxanide furoate</strong> to clear any intraluminal cysts/trophozoites and prevent relapse. <strong>(Option D ruled out)</strong></li>\n</ul>\n<p><strong>Metronidazole:</strong></p>\n<p>Nitroimidazole <strong>antiprotozoal</strong> and <strong>antibacterial</strong> agent.</p>\n<p><strong>Mechanism of Action:</strong></p>\n<ul>\n<li><strong>Selective uptake</strong> by <strong>anaerobic bacteria</strong> and certain protozoa.</li>\n<li>Inside anaerobes, <strong>non-enzymatic reduction</strong> occurs via <strong>reduced ferredoxin</strong>.</li>\n<li>Form <strong>toxic free radical metabolites</strong> that <strong>disrupt bacterial DNA</strong> &rarr; Unstable molecules &rarr; Cell death.</li>\n<li>This process occurs <strong>only in anaerobes</strong>, making the drug <strong>safe for human cells and aerobic bacteria</strong>.</li>\n</ul>\n<p><strong>Clinical Indications:</strong></p>\n<ul>\n<li>Anaerobic &amp; mixed intra-abdominal infections</li>\n<li><strong>Pelvic inflammatory disease</strong> (PID) with agents covering aerobes</li>\n<li><strong>Vaginitis:</strong>\n<ul>\n<li><em>Trichomonas vaginalis</em></li>\n<li><em>Bacterial vaginosis</em></li>\n</ul>\n</li>\n<li><strong>Amebiasis, giardiasis</strong></li>\n<li><strong>Brain abscess</strong></li>\n<li><strong>Clostridioides difficile i</strong>nfection (no longer first-line alone). Used IV with oral vancomycin in fulminant cases</li>\n</ul>\n<p><strong>Adverse Effects:</strong></p>\n<ul>\n<li>Common side effects are <strong>Nausea</strong>, <strong>diarrhea, </strong>and<strong> Stomatitis</strong></li>\n<li><strong>Peripheral neuropathy</strong> (especially with prolonged use)</li>\n<li><strong>Disulfiram-like reaction with alcohol</strong>: Traditionally believed, but recent evidence suggests this may not be significant.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Ofloxacin(Option A): </strong>It is a fluoroquinolone antibacterial, not effective against Entamoeba</p>\n<p><strong>Meropenem(Option C):</strong> Broad-spectrum antibacterial, not active against protozoa</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">500 mg OD</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">500 mg BD</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">500 mg TDS</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">500 mg QDS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old male alcoholic patient is brought to the emergency department with the complaints of severe pain in the right hypochondriac region, Vomiting, high-grade fever, weakness, and difficulty in breathing. His laboratory investigation and USG were performed. USG was suggestive of multiple liver abscesses. The physician wants to start intravenous metronidazole therapy. What should be the dose of IV Metronidazole in this patient?</span></p>",
      "unique_key": "DT1176808",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176808,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240322010c6283-b3c5-4cbd-b63e-a8dabafb173a.jpg\">",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Dry mouth</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Headache</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Metallic taste in the mouth</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the adverse effect of metronidazole?</span></p>",
      "unique_key": "DT1176811",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176811,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Nausea, <strong>headache</strong>, <strong>dry mouth</strong>, or a <strong>metallic taste</strong> in the mouth occur commonly. Infrequent adverse effects include vomiting, diarrhoea, insomnia, weakness, dizziness, thrush, rash, dysuria, dark urine, vertigo, paraesthesia, and neutropenia.</li>\n<li>Taking the drug with meals lessens gastrointestinal irritation.</li>\n<li>Pancreatitis and severe central nervous system toxicity (ataxia, encephalopathy, seizures) are rare.</li>\n<li>Metronidazole has a disulfiram-like effect, so that nausea and vomiting can occur if alcohol is ingested during therapy.</li>\n<li>The drug should be used with caution in patients with central nervous system disease.</li>\n<li>Intravenous infusions have rarely caused seizures or peripheral neuropathy.</li>\n<li>The dosage should be adjusted for patients with severe liver or renal disease.</li>\n<li>Tinidazole has a similar adverse-effect profile, although it appears to be somewhat better tolerated than metronidazole.</li>\n</ul>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydatid diseases</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Cysticercosis</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">A&B both</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Pinworm infestation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Albendazole is the drug of choice for__________.</span></p>",
      "unique_key": "DT1176813",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176813,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Albendazole, a broad-spectrum oral antihelminthic, is the drug of choice and is approved in the USA for the treatment of <strong>hydatid disease and cysticercosis.</strong></p>\n<p><strong>Albendazole:</strong></p>\n<ul>\n<li><strong>Albendazole</strong> is a broad-spectrum antihelminthic agent from the benzimidazole class. It works by inhibiting microtubule polymerization and glucose uptake in parasites, leading to energy depletion and death of the helminth.</li>\n<li>Albendazole is best taken <strong>with a fatty meal</strong> to enhance systemic absorption, especially when treating <strong>tissue parasites</strong> like hydatid cysts and cysticercosis.</li>\n</ul>\n<p><strong>Clinical Uses</strong></p>\n<h4><strong>1. Intestinal Helminth Infections</strong></h4>\n<ul>\n<li><strong>Ascariasis, pinworm</strong>: 400 mg single dose orally<em>. </em>Repeat after 2-3 days (for heavy infections) or after 2 weeks (for pinworm).</li>\n<li><strong>Hookworm, trichuriasis</strong>: <em>400 mg daily &times; 3 days. </em>Combination with ivermectin or oxantel pamoate improves efficacy.</li>\n</ul>\n<h4><strong>2. Hydatid Disease (Echinococcus granulosus)</strong></h4>\n<ul>\n<li><strong>Drug of choice</strong></li>\n<li>400 mg twice daily with meals &times; 1 month or more (up to 6 months)</li>\n<li>Combined with <strong>praziquantel or surgery</strong> as needed.</li>\n</ul>\n<h4><strong>3. Neurocysticercosis</strong></h4>\n<ul>\n<li>Most effective for <strong>parenchymal or intraventricular cysts</strong>.</li>\n<li>400 mg twice daily &times; up to 21 days</li>\n<li><strong>Given corticosteroids</strong> to prevent an inflammatory response.</li>\n<li>Superior to praziquantel in:<br />\n<ul>\n<li>Subarachnoid penetration</li>\n<li>Cost-effectiveness</li>\n<li>Drug levels when co-administered with steroids.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Roundworms (Nematodes)</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904389f9600-f852-41a7-8db7-4cfca5673c9e.png\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904b588d3ff-9812-4ff7-b985-29e57b5d5eea.png\">\n<p><strong>Flukes (Trematodes)</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509042112cefd-f22c-460d-be4f-071222d06885.png\">\n<p><strong>Tapeworms (Cestodes)</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509047e18fbb9-79ac-4a50-99c5-fc13f6889f60.png\">",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Insomnia</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Nausea</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancytopenia</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the adverse effect of long-term use of albendazole?</span></p>",
      "unique_key": "DT1176818",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176818,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>When used for 1-3 days, albendazole is nearly free of significant adverse effects.</li>\n<li><strong>Mild and transient</strong> epigastric distress, diarrhoea, headache, nausea, dizziness, lassitude, and insomnia can occur.<strong>(Option A and B ruled out)</strong></li>\n<li>In <strong>long-term use</strong> for hydatid disease, albendazole is well tolerated, but it can cause abdominal distress, headaches, fever, fatigue, alopecia, increases in liver enzymes, and pancytopenia.</li>\n<li>Blood counts and liver function studies should be monitored during <strong>long-term therapy</strong>.</li>\n<li>The drug should not be given to patients with known hypersensitivity to other benzimidazole drugs or to those with cirrhosis.</li>\n<li>The safety of albendazole in pregnancy and in children younger than 2 years of age has not been established.</li>\n</ul>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Strongyloidiasis</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Onchocerciasis</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">A&B both</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumocystis pneumonia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ivermectin is widely used as an antiparasitic agent and serves as an alternative in various helminthic infections. For which of the following conditions is Ivermectin considered the drug of choice?</span></p>",
      "unique_key": "DT1176826",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176826,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Ivermectin</strong> is the drug of choice in <strong>strongyloidiasis</strong> and <strong>onchocerciasis</strong>.</li>\n<li>It is also an alternative drug for a number of other helminthic infections.</li>\n</ul>\n<p><strong>Ivermectin:</strong> </p>\n<p>Ivermectin is a <strong>Semisynthetic macrocyclic lactone </strong></p>\n<p><strong>Mechanism of Action:</strong></p>\n<ul>\n<li>Binds to <strong>glutamate-gated chloride channels</strong> in nerve and muscle cells of parasites &rarr; <strong>paralysis and death</strong></li>\n<li>Also enhances <strong>GABA-mediated neurotransmission</strong> in the peripheral nerves of parasites</li>\n<li><strong>Does not cross the human blood-brain barrier significantly</strong> (hence relatively safe in humans)</li>\n</ul>\n<p><strong>Clinical Uses:</strong></p>\n<h4><strong>1. Onchocerciasis (River Blindness)</strong></h4>\n<ul>\n<li><strong>Drug of choice</strong></li>\n<li>Dose: <strong>150 mcg/kg single oral dose</strong>, repeated every 12 months</li>\n<li><strong>Microfilaricidal</strong>: Reduces skin microfilariae within 2-3 days</li>\n<li><strong>Does not kill adult worms</strong>, but reduces microfilarial release</li>\n<li><strong>Adjuvant corticosteroids</strong> are used in patients with ocular involvement to reduce inflammation</li>\n<li><strong>Long-term treatment</strong> (up to 10 years) is needed to wait out the adult worm's lifespan</li>\n<li><strong>Mass drug administration programs</strong> use ivermectin for transmission control</li>\n<li><strong>Resistance concerns</strong>: Decreased response seen in high-transmission areas</li>\n</ul>\n<h4><strong>2. Strongyloidiasis</strong></h4>\n<ul>\n<li><strong>Drug of choice</strong></li>\n<li>Dose: <strong>200 mcg/kg once daily for 2 days</strong></li>\n<li>In <strong>immunosuppressed or disseminated cases</strong>, prolonged or monthly suppressive therapy may be needed</li>\n<li>More effective than albendazole in severe cases</li>\n</ul>\n<h4><strong>3. Other Uses</strong></h4>\n<ul>\n<li><strong>Bancroftian Filariasis (W. bancrofti):</strong> Used with albendazole + DEC in MDA programs; <strong>not adulticidal</strong></li>\n<li><strong>Brugia malayi, Mansonella ozzardi:</strong> &darr; microfilariae</li>\n<li><strong>Loa loa (Loiasis):</strong> Reduces microfilariae, but may cause severe adverse reactions; <strong>DEC preferred</strong></li>\n<li><strong>Scabies and Lice:</strong> Topical and oral ivermectin used effectively</li>\n<li><strong>Cutaneous larva migrans</strong> and <strong>Ascaris</strong>: Effective against larvae and adult worms</li>\n<li><strong>Malaria vector control (experimental):</strong> Reduces the mosquito lifespan when they feed on treated individuals</li>\n</ul>\n<p><strong>Adverse Effects:</strong></p>\n<p><strong>General (in Strongyloidiasis): </strong>Fatigue, dizziness, nausea, vomiting, Abdominal pain, rash</p>\n<h4><strong>In Onchocerciasis (due to microfilarial death):</strong></h4>\n<ul>\n<li><strong>Mild (5-30%):</strong> Fever, headache, dizziness, weakness, rash, pruritus, diarrhea, joint/muscle pain, hypotension, tachycardia, lymphadenitis, edema</li>\n<li><strong>Moderate to severe (1-3%):</strong> High fever, bronchospasm, hypotension</li>\n<li><strong>Rare (0.1%):</strong> Intense inflammatory reactions</li>\n<li><strong>Management:</strong> Corticosteroids for severe systemic or ocular reactions</li>\n<li><strong>Eye lesions:</strong> Corneal opacities, usually self-resolving</li>\n</ul>\n<p><strong>Contraindications &amp; Cautions:</strong></p>\n<ul>\n<li>Avoid <strong>co-administration with GABAergic drugs</strong> (e.g., barbiturates, benzodiazepines, valproic acid)</li>\n<li><strong>Pregnancy:</strong> Contraindicated (Category C)</li>\n<li><strong>Children &lt;5 years:</strong> Safety not established</li>\n</ul>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Albendazole</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Ivermectin</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Diethylcarbamazine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Mebendazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old man with nocturnal fever and leg swelling is diagnosed with Wuchereria bancrofti. Which is the first-line drug for treatment and also useful for mass prophylaxis?</span></p>",
      "unique_key": "DT1176829",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Diethylcarbamazine</strong> is a drug of choice in the treatment of <strong>filariasis, loiasis, and tropical eosinophilia.</strong></li>\n<li>It has been replaced by ivermectin for the treatment of onchocerciasis.</li>\n</ul>\n<p><strong>Diethylcarbamazine:</strong></p>\n<p>Antifilarial drug, which is a <strong>Synthetic piperazine derivative</strong></p>\n<p><strong>Mechanism of Action:</strong></p>\n<ul>\n<li>Immobilizes <strong>microfilariae</strong></li>\n<li>Alters <strong>surface structure</strong> and facilitates immune-mediated destruction</li>\n<li>The adulticidal mechanism is <strong>unknown<br /> </strong></li>\n</ul>\n<h4><strong>Drug of Choice For:</strong></h4>\n<ul>\n<li>Lymphatic Filariasis (<em>Wuchereria bancrofti, Brugia malayi, B. timori</em>)</li>\n<li>Loiasis (<em>Loa loa</em>)</li>\n<li>Tropical Pulmonary Eosinophilia</li>\n<li>Mansonella streptocerca infections (kills adults &amp; microfilariae)<br /> <strong>Note: Not effective against Onchocerciasis, where ivermectin is preferred.</strong></li>\n</ul>\n<p><strong>Adverse Effects &amp; Precautions:</strong></p>\n<ul>\n<li><strong>Allergic reactions (due to rapid killing of microfilariae)<br /> </strong>Can be managed with:<br />\n<ul>\n<li>Antihistamines</li>\n<li>Corticosteroids</li>\n</ul>\n</li>\n<li>In high <em>Loa loa</em> burden (&gt;2500/mL), there is an increased risk of <strong>encephalopathy<br /> </strong>Use pre-treatment strategies:\n<ul>\n<li><strong>Apheresis (removal of microfilariae)</strong></li>\n<li><strong>Albendazole first (slow-acting, safer), then DEC/ivermectin</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Albendazole(Option A): </strong>Broad-spectrum anthelmintic used against <strong>Soil-transmitted helminths</strong>, <strong>neurocysticercosis</strong>, and <strong>hydatid disease. Used in filariasis</strong> <strong>only as a combination partner</strong> in MDA programs. <strong>Monotherapy with albendazole is not effective</strong> against microfilariae or adult filarial worms in <em>W. bancrofti</em>.</p>\n<p><strong>Ivermectin(Option B): </strong>DOC for <strong>Onchocerciasis </strong>and <strong>Strongyloidiasis. </strong>In <strong>W. bancrofti</strong>, it is <strong>Microfilaricidal </strong>only, does not kill adult worms</p>\n<p><strong>Mebendazole(Option D): </strong>Mainly used in Intestinal helminths like <strong>Ascariasis</strong>, <strong>Enterobiasis</strong>, <strong>Trichuriasis</strong>, and <strong>Hookworm</strong>. Not used in <strong>filarial infections</strong></p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Ivermectin</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">DEC</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Henderson - Hasselbach trapping effect is seen in__________.</span></p>",
      "unique_key": "DT1176830",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Diethylcarbamazine, a synthetic piperazine derivative, is marketed as a citrate salt.</li>\n<li>It is rapidly absorbed from the gastrointestinal tract; after a 0.5 mg/kg dose, peak plasma levels are reached within 1-2 hours.</li>\n<li>The plasma half-life is 2-3 hours in the presence of acidic urine but about 10 hours if the urine is alkaline, a <strong>Henderson-Hasselbalch trapping effect</strong>.</li>\n<li>The drug rapidly equilibrates with all tissues except fat.</li>\n<li>It is excreted, principally in the urine, as the unchanged drug and the N-oxide metabolite.</li>\n<li>Dosage may have to be reduced in patients with persistent urinary alkalosis or renal impairment.</li>\n<li>Diethylcarbamazine immobilizes microfilariae and alters their surface structure, displacing them from tissues and making them more susceptible to destruction by host defence mechanisms.</li>\n<li>The mode of action against adult worms is unknown.</li>\n</ul>\n<p><strong>Henderson-Hasselbalch Trapping:</strong><strong> </strong></p>\n<p>This concept explains how weakly acidic or basic drugs can get trapped in compartments (like urine or the stomach) based on the pH difference across membranes.</p>\n<ul>\n<li>Only unionized drugs can freely cross cell membranes.</li>\n<li>Ionized forms are water-soluble but cannot cross lipid membranes easily.</li>\n<li>So, if a drug crosses into a compartment and gets ionized, it gets trapped there.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Ivermectin(Option A): </strong>Ivermectin is <strong>not significantly affected by urinary pH. </strong>Its distribution and metabolism are not dependent on acid-base trapping mechanisms</p>\n<p><strong>Metronidazole(Option C): </strong>Metronidazole is a <strong>nitroimidazole antibiotic. </strong>It is metabolized primarily in the <strong>liver</strong>, not significantly affected by urinary pH. No known Henderson-Hasselbalch trapping effect.</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Pinworm</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Hookworm</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichuriasis</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Ascaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following helminthic infections is Pyrantel pamoate not effective against?</span></p>",
      "unique_key": "DT1176831",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Pyrantel pamoate</strong> is a broad-spectrum antihelminthic highly effective for the treatment of <strong>pinworm, ascaris</strong>, and <strong>Trichostrongylus orientalis</strong></li>\n<li>It is moderately effective against both species of hookworm.</li>\n<li>It is not effective in <strong>trichuriasis</strong> or <strong>strongyloidiasis</strong>.</li>\n</ul>\n<p><strong>Note: Oxantel pamoate</strong>, an analog of pyrantel not available in the USA, has been used successfully in the treatment of t<strong>richuriasis</strong>; the two drugs have been combined for their broad-spectrum antihelminthic activity</p>\n<p><strong>Pyrantel pamoate:</strong> </p>\n<ul>\n<li><strong>Class</strong>: Tetrahydropyrimidine derivative</li>\n<li><strong>Action</strong>: Neuromuscular blocker which causes <strong>ACh release</strong> &amp; <strong>cholinesterase inhibition leading to</strong> <strong>spastic paralysis</strong> of worms and expulsion</li>\n<li><strong>Absorption</strong>: Poorly absorbed; acts <strong>mainly in the intestinal lumen</strong></li>\n<li><strong>Excretion</strong>: &gt;50% eliminated unchanged in feces</li>\n<li><strong>Effective against</strong>: <strong>Mature &amp; immature</strong> worms in the GIT</li>\n<li><strong>Not effective against</strong>: Migratory tissue stages or ova</li>\n</ul>\n<p><strong>Adverse Effects</strong></p>\n<ul>\n<li>Usual <strong>mild and transient</strong> side effects are:\n<ul>\n<li>GI: Nausea, vomiting, cramps, diarrhea</li>\n<li>CNS: Dizziness, drowsiness, headache, insomnia</li>\n<li>Others: Rash, fever, weakness</li>\n</ul>\n</li>\n<li><strong>Liver caution</strong>: May cause <strong>transient transaminase elevation</strong></li>\n<li>Use with caution in <strong>liver dysfunction</strong>, in <strong>children &lt;2 years,</strong> and during <strong>pregnancy </strong>(limited data)</li>\n</ul>\n<p><strong>Clinical Use</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090452a8fd3e-5a29-463f-a3c1-5622e85748c8.png\">",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Sentence 1 and 2 both are True, and 2 is the correct reason for 1</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Sentences 1 and 2 both are True, but 2 is not the correct reason for 1</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Sentence 1 is True, but Sentence 2 is False</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Sentences 1 and 2 are both False.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">1. Pyrantal pamoate acts by paralysing the worm <br>2. It is a neuromuscular blocking agent</span></p>",
      "unique_key": "DT1176832",
      "question_audio": null,
      "question_video": null,
      "map_id": 1176832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Pyrantel pamoate is a <strong>tetrahydro pyrimidine derivative.</strong></li>\n<li>The drug is a neuromuscular blocking agent that causes r<strong>elease of acetylcholine</strong> and <strong>inhibition of cholinesterase</strong>; this results in paralysis of worms, which is followed by expulsion.</li>\n<li>It is poorly absorbed from the gastrointestinal tract and is active mainly against luminal organisms.</li>\n<li>Peak plasma levels are reached in 1-3 hours.</li>\n<li>Over half of the administered dose is recovered unchanged in the faeces.</li>\n<li>Pyrantel is effective against mature and immature forms of susceptible helminths within the intestinal tract but not against migratory stages in the tissues or ova.</li>\n</ul>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}